A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate how the body responds to evacetrapib and to
evaluate the safety and the effect of evacetrapib, alone and in combination with selected
statins, in healthy Chinese participants. The study has 2 parts. Part one will last up to 4
weeks and part two will last up to 5 weeks, not including screening. Participants may only
enroll in one part.